慢性精神分裂症后诊断为抗nmda受体脑炎:病例报告及文献复习。

Q4 Medicine Clinical Schizophrenia and Related Psychoses Pub Date : 2018-01-01 Epub Date: 2017-08-04 DOI:10.3371/CSRP.MCTF.071317
Meghan A Conroy, Thomas Finch, Tomer T Levin, Alexander E Merkler, Joseph Safdieh, Susan Samuels, Janna S Gordon Elliott
{"title":"慢性精神分裂症后诊断为抗nmda受体脑炎:病例报告及文献复习。","authors":"Meghan A Conroy, Thomas Finch, Tomer T Levin, Alexander E Merkler, Joseph Safdieh, Susan Samuels, Janna S Gordon Elliott","doi":"10.3371/CSRP.MCTF.071317","DOIUrl":null,"url":null,"abstract":"Introduction Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disorder caused by Ig G auto-Ab directed against the NR1 subunit of the NMDA glutamate receptor (1). The binding of IgG antibodies induces a reversible internalization of the receptors (2). Decreased activity of NMDA receptors is known to be associated with both the positive and negative symptoms of schizophrenia (3). The early stages of the illness are characterized by psychiatric symptoms. As the illness progresses, neurologic symptoms emerge, and in the most severe stage of the illness, autonomic instability and respiratory collapse can occur. During the stage of the illness when psychiatric symptoms predominate in the presentation, anti-NMDAR encephalitis may be misattributed to a primary psychiatric disorder. Most of the literature thus far has described such misdiagnoses in patients with first-episode psychosis (4-6). There appear to be no documented cases of chronic schizophrenia that were definitely later reclassified as anti-NMDAR encephalitis. Here we report what we believe to be the first reported case of misdiagnosis of anti-NMDAR encephalitis as chronic schizophrenia. Case Report Ms. A is a 25-year-old female with a history of schizophrenia diagnosed four years prior and multiple subsequent psychiatric hospitalizations, who was evaluated in our medical emergency department, transferred from an outside psychiatric inpatient unit, for investigation of altered mental status (AMS), unilateral facial stiffness, and cough. Psychiatry was consulted. She was noted to be disorganized and agitated and had unilateral facial twitching. Her medications included lithium, divalproex sodium, clozapine, and the long-acting injectable formulation of paliperidone palmitate (last dose two weeks prior). An infectious workup was unremarkable. Intravenous lorazepam, given as empiric treatment for suspected catatonia, rendered no benefit. She was discharged back to the inpatient psychiatric facility. One week later she re-presented to this hospital with difficulty breathing and frothing at the mouth. She was noted to be conscious and awake, intermittently physically agitated, but nonverbal and not following commands or withdrawing from painful stimuli. Rhythmic orofacial grimacing was prominent with intermittent unilateral lead-pipe rigidity. She had autonomic instability with variable heart rate and blood pressures. Creatine kinase (CK) was initially elevated to 972 and peaked at 1,797. She was admitted to the medical intensive care unit (ICU) with neurology and psychiatry consulting. The differential diagnosis included delirium, severe antipsychotic-mediated extrapyramidal symptoms and neuroleptic malignant syndrome (NMS). Supportive care and amantadine were started for suspected NMS. Lumbar puncture (LP) showed mild elevation in the cerebrospinal fluid (CSF) white blood cell count (13/uL), with 98% lymphocyte predominance and normal protein and glucose. In","PeriodicalId":40019,"journal":{"name":"Clinical Schizophrenia and Related Psychoses","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Chronic Schizophrenia Later Diagnosed with Anti-NMDA Receptor Encephalitis: Case Report and Review of the Literature.\",\"authors\":\"Meghan A Conroy, Thomas Finch, Tomer T Levin, Alexander E Merkler, Joseph Safdieh, Susan Samuels, Janna S Gordon Elliott\",\"doi\":\"10.3371/CSRP.MCTF.071317\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disorder caused by Ig G auto-Ab directed against the NR1 subunit of the NMDA glutamate receptor (1). The binding of IgG antibodies induces a reversible internalization of the receptors (2). Decreased activity of NMDA receptors is known to be associated with both the positive and negative symptoms of schizophrenia (3). The early stages of the illness are characterized by psychiatric symptoms. As the illness progresses, neurologic symptoms emerge, and in the most severe stage of the illness, autonomic instability and respiratory collapse can occur. During the stage of the illness when psychiatric symptoms predominate in the presentation, anti-NMDAR encephalitis may be misattributed to a primary psychiatric disorder. Most of the literature thus far has described such misdiagnoses in patients with first-episode psychosis (4-6). There appear to be no documented cases of chronic schizophrenia that were definitely later reclassified as anti-NMDAR encephalitis. Here we report what we believe to be the first reported case of misdiagnosis of anti-NMDAR encephalitis as chronic schizophrenia. Case Report Ms. A is a 25-year-old female with a history of schizophrenia diagnosed four years prior and multiple subsequent psychiatric hospitalizations, who was evaluated in our medical emergency department, transferred from an outside psychiatric inpatient unit, for investigation of altered mental status (AMS), unilateral facial stiffness, and cough. Psychiatry was consulted. She was noted to be disorganized and agitated and had unilateral facial twitching. Her medications included lithium, divalproex sodium, clozapine, and the long-acting injectable formulation of paliperidone palmitate (last dose two weeks prior). An infectious workup was unremarkable. Intravenous lorazepam, given as empiric treatment for suspected catatonia, rendered no benefit. She was discharged back to the inpatient psychiatric facility. One week later she re-presented to this hospital with difficulty breathing and frothing at the mouth. She was noted to be conscious and awake, intermittently physically agitated, but nonverbal and not following commands or withdrawing from painful stimuli. Rhythmic orofacial grimacing was prominent with intermittent unilateral lead-pipe rigidity. She had autonomic instability with variable heart rate and blood pressures. Creatine kinase (CK) was initially elevated to 972 and peaked at 1,797. She was admitted to the medical intensive care unit (ICU) with neurology and psychiatry consulting. The differential diagnosis included delirium, severe antipsychotic-mediated extrapyramidal symptoms and neuroleptic malignant syndrome (NMS). Supportive care and amantadine were started for suspected NMS. Lumbar puncture (LP) showed mild elevation in the cerebrospinal fluid (CSF) white blood cell count (13/uL), with 98% lymphocyte predominance and normal protein and glucose. In\",\"PeriodicalId\":40019,\"journal\":{\"name\":\"Clinical Schizophrenia and Related Psychoses\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Schizophrenia and Related Psychoses\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3371/CSRP.MCTF.071317\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2017/8/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Schizophrenia and Related Psychoses","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3371/CSRP.MCTF.071317","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/8/4 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 4
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Chronic Schizophrenia Later Diagnosed with Anti-NMDA Receptor Encephalitis: Case Report and Review of the Literature.
Introduction Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disorder caused by Ig G auto-Ab directed against the NR1 subunit of the NMDA glutamate receptor (1). The binding of IgG antibodies induces a reversible internalization of the receptors (2). Decreased activity of NMDA receptors is known to be associated with both the positive and negative symptoms of schizophrenia (3). The early stages of the illness are characterized by psychiatric symptoms. As the illness progresses, neurologic symptoms emerge, and in the most severe stage of the illness, autonomic instability and respiratory collapse can occur. During the stage of the illness when psychiatric symptoms predominate in the presentation, anti-NMDAR encephalitis may be misattributed to a primary psychiatric disorder. Most of the literature thus far has described such misdiagnoses in patients with first-episode psychosis (4-6). There appear to be no documented cases of chronic schizophrenia that were definitely later reclassified as anti-NMDAR encephalitis. Here we report what we believe to be the first reported case of misdiagnosis of anti-NMDAR encephalitis as chronic schizophrenia. Case Report Ms. A is a 25-year-old female with a history of schizophrenia diagnosed four years prior and multiple subsequent psychiatric hospitalizations, who was evaluated in our medical emergency department, transferred from an outside psychiatric inpatient unit, for investigation of altered mental status (AMS), unilateral facial stiffness, and cough. Psychiatry was consulted. She was noted to be disorganized and agitated and had unilateral facial twitching. Her medications included lithium, divalproex sodium, clozapine, and the long-acting injectable formulation of paliperidone palmitate (last dose two weeks prior). An infectious workup was unremarkable. Intravenous lorazepam, given as empiric treatment for suspected catatonia, rendered no benefit. She was discharged back to the inpatient psychiatric facility. One week later she re-presented to this hospital with difficulty breathing and frothing at the mouth. She was noted to be conscious and awake, intermittently physically agitated, but nonverbal and not following commands or withdrawing from painful stimuli. Rhythmic orofacial grimacing was prominent with intermittent unilateral lead-pipe rigidity. She had autonomic instability with variable heart rate and blood pressures. Creatine kinase (CK) was initially elevated to 972 and peaked at 1,797. She was admitted to the medical intensive care unit (ICU) with neurology and psychiatry consulting. The differential diagnosis included delirium, severe antipsychotic-mediated extrapyramidal symptoms and neuroleptic malignant syndrome (NMS). Supportive care and amantadine were started for suspected NMS. Lumbar puncture (LP) showed mild elevation in the cerebrospinal fluid (CSF) white blood cell count (13/uL), with 98% lymphocyte predominance and normal protein and glucose. In
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical Schizophrenia and Related Psychoses
Clinical Schizophrenia and Related Psychoses Medicine-Psychiatry and Mental Health
自引率
0.00%
发文量
0
期刊介绍: The vision of the exciting new peer-reviewed quarterly publication Clinical Schizophrenia & Related Psychoses (CS) is to provide psychiatrists and other healthcare professionals with the latest research and advances in the diagnosis and treatment of schizophrenia and related psychoses. CS is a practice-oriented publication focused exclusively on the newest research findings, guidelines, treatment protocols, and clinical trials relevant to patient care.
期刊最新文献
Dysexecutive Behavior in First-Episode Schizophrenia. Dysexecutive Behavior in First-Episode Schizophrenia Grading meningiomas by used imaging features on magnetic resonance imaging The Association between Serum Levels of Ferritin and D-Dimer with Liver Function Tests in Patients with COVID-19 Role of Susceptibility Weighted Magnetic Resonance Imaging in Neurological Diagnosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1